Beliefs About Medicines and Adherence to Biologic Therapy in Patients with Moderate-to-Severe Psoriasis: A Cross-Sectional Study
Maja Pavić, Joško Markić, Adela Markota Čagalj, Zdenka Šitum Čeprnja et autres
Background and Objectives: Psoriasis is a chronic, immune-mediated inflammatory dermatosis affecting approximately 125 million people worldwide. Biologic therapy (BT) has significantly improved treatment outcomes for moderate-to-severe psoriasis, but real-world adherence to these therapies is not fully understood. This study aimed to evaluate …
hr (code pays fourni par la source)